Cas:158654-75-2 isoquinoline,7-(bromomethyl)-(9CI) manufacturer & supplier

We serve Chemical Name:isoquinoline,7-(bromomethyl)-(9CI) CAS:158654-75-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

isoquinoline,7-(bromomethyl)-(9CI)

Chemical Name:isoquinoline,7-(bromomethyl)-(9CI)
CAS.NO:158654-75-2
Synonyms:Isoquinoline, 7-(bromomethyl)-;7-(Bromomethyl)isoquinoline;7-bromomethylisoquinoline;isoquinoline,7-(bromomethyl)-(9CI)
Molecular Formula:C10H8BrN
Molecular Weight:222.081
HS Code:2933499090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:337.3±17.0 °C at 760 mmHg
Density:1.5±0.1 g/cm3
Index of Refraction:1.673
PSA:12.89000
Exact Mass:220.984009
LogP:2.66

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like Isoquinoline, 7-(bromomethyl)- chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,isoquinoline,7-(bromomethyl)-(9CI) physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,7-(Bromomethyl)isoquinoline Use and application,isoquinoline,7-(bromomethyl)-(9CI) technical grade,usp/ep/jp grade.


Related News: Further research on Oligomannate��s pharmacological mechanism and long-term safety and effectiveness is required, according to the NMPA statement. isoquinoline,7-(bromomethyl)-(9CI) manufacturer Further research on Oligomannate��s pharmacological mechanism and long-term safety and effectiveness is required, according to the NMPA statement. isoquinoline,7-(bromomethyl)-(9CI) supplier In August, the Company announced that the U.S. Patent and Trademark Office issued U.S. Patent No. 10,370,452 covering compositions and uses of effector T cells expressing a CAR, where such T cells are derived from a pluripotent stem cell, including an iPSC. isoquinoline,7-(bromomethyl)-(9CI) vendor Further research on Oligomannate��s pharmacological mechanism and long-term safety and effectiveness is required, according to the NMPA statement. isoquinoline,7-(bromomethyl)-(9CI) factory The fine and functional chemicals sector provides new growth drivers.